Inflammation is the complex physiological response to tissue injury or infection. Leukocyte recruitment is an important feature of inflammation. Leukocyte recruitment is regulated by small proteins called chemokines, which are secreted at the site of injury or infection, binding to chemokine receptors expressed on the target leukocyte. As an evolutionary strategy, ticks have been found to secrete small chemokine binding proteins (CBPs) called evasins, which suppress the host inflammatory response, enabling the tick to avoid detection and prolong blood feeding (1). Inhibition of specific chemokines is crucial for preventing inflammation. As such, evasins are natural, selective chemokine-inhibitory proteins with excellent potential as therapeutics for inflammatory diseases. In recent years, we and others have discovered a large family of tick evasins that bind and inhibit chemokines (2,3). In this study, we have used bioinformatics methods to discover a novel family of these CBPs that contain tandem repeats of evasin-like sequences. Furthermore, we have combined the use of molecular biology, protein chemistry and biophysical methods to verify and characterise the binding of tandem domain evasins to chemokines. Our work may pave the way for the development of new therapeutic agents against inflammation.